Skip Navigation LinksHome > May 2014 - Volume 20 - Issue 3 > Memantine in the Treatment and Prophylaxis of Bipolar II Dis...
Journal of Psychiatric Practice:
doi: 10.1097/01.pra.0000450324.44661.12
Clinical Case Discussions

Memantine in the Treatment and Prophylaxis of Bipolar II Disorder and Comorbid Fibromyalgia: A Case Report

SERRA, GIULIA MD; DE CHIARA, LAVINIA MD; KOUKOPOULOS, ALEXIA EMILIA MD; KOUKOPOULOS, ATHANASIOS MD; SERRA, GINO MD; KAHN, DAVID A. MD

Collapse Box

Abstract

We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy. We have also observed an acute antimanic and sustained mood-stabilizing effect in a small number of patients with bipolar I disorder who had had minimal previous pharmacotherapy. In this article, we report the case of a young woman suffering from bipolar II disorder with associated fibromyalgia, in whom memantine showed an acute antimanic and a long-term prophylactic effect on both bipolar disorder as well as the associated fibromyalgia syndrome. (Journal of Psychiatric Practice 2014;20:232–236)

© 2014 by Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.